Evidence-Based Complementary and Alternative Medicine

Research Article

A New Rehabilitation Tool in Fibromyalgia: The Effects of Perceptive Rehabilitation on Pain and Function in a Clinical Randomized Controlled Trial

Table 2

Mean ± standard deviation of clinical scores for the three groups for the three assessment times. values in the last column for each scale refer to within-group Friedman analysis, whereas the values in the lower rows refer to group comparisons based on Kruskal-Wallis analysis, with upper and lower bounds of the 95% confidence interval (95% CI). values are reported in bold if statistically significant. Effect size is reported in the last rows for the comparisons between groups.
ScaleFIQ value (FR)FAS value (FR)HAQ value (FR)
Time of assessmentT0T1T2T0T1T2T0T1T2
PS-group68.0 ± 13.056.0 ± 13.055.0 ± 14.0<0.0017.1 ± 1.25.8 ± 1.35.5 ± 1.6<0.0011.1 ± 0.51.0 ± 0.60.9 ± 0.60.846
PE-group66.0 ± 13.054.0 ± 10.054.0 ± 11.00.0037.2 ± 1.36.0 ± 0.85.8 ± 0.80.0031.3 ± 0.61.0 ± 0.60.9 ± 0.7<0.001
CG64.0 ± 9.066.0 ± 10.066.0 ± 10.00.0027.4 ± 1.27.0 ± 1.37.0 ± 1.40.1281.3 ± 0.41.5 ± 0.41.6 ± 0.40.015
values (KW)0.3290.0130.007 0.8650.0040.004 0.2820.0090.001 
95% CI            
 UB0.3200.0100.004 0.847<0.001<0.001 0.2350.001<0.001 
 LB0.3800.0260.016 0.8890.0040.005 0.2890.0110.005 
ES            
 PS-group and CG0.409−0.839−0.970 −0.251−0.929−1.007 −0.599−1.077−1.263 
 PE-group and CG0.176−1.173−1.185 −0.157−0.938−1.013 0.003−0.992−1.191 
 PS-group and PE-group−0.2000.0840.523 0.0840.1910.253 0.5230.084−0.022 
FIQ: Fibromyalgia Impact Questionnaire, FAS: Fibromyalgia Assessment Status, HAQ: Health Assessment Questionnaire, PS-group: perceptive surfaces group, PE: physical exercises group, CG: control group, T0: baseline, T1: end of the treatment, T2: follow-up, FR: Friedman analysis, KW: Kruskal-Wallis analysis, UB and LB: upper and lower bounds ES, and Cohen’s : effect size.